Special Issue: Non-Pharmacological Interventions for People with Parkinson's Disease: Are We Entering a New Era?

Affiliations

¹ Medical Psychology | Neuropsychology and Gender Studies & Center for Neuropsychological Diagnostics and Intervention (CeNDI), University Hospital Cologne and Medical Faculty of the University of Cologne, Cologne, Germany.
² Radboud University Medical Centre, Donders Institute for Brain, Cognition and Behaviour, Department of Neurology, Centre of Expertise for Parkinson and Movement Disorders, Nijmegen, The Netherlands.
³ Krembil Research Institute, Edmond J. Safra Program in Parkinson's Disease and the Morton and Gloria Shulman Movement Disorders Clinic, Toronto Western Hospital, University Health Network, Toronto, Canada.
⁴ Department of Rehabilitation Sciences, Research Group for Neurorehabilitation (eNRGy), KU Leuven, Leuven, Belgium.

Editorial

E Kalbe et al. J Parkinsons Dis. 2024.

. 2024;14(s1):S1-S4.

doi: 10.3233/JPD-249009.

¹ Medical Psychology | Neuropsychology and Gender Studies & Center for Neuropsychological Diagnostics and Intervention (CeNDI), University Hospital Cologne and Medical Faculty of the University of Cologne, Cologne, Germany.
² Radboud University Medical Centre, Donders Institute for Brain, Cognition and Behaviour, Department of Neurology, Centre of Expertise for Parkinson and Movement Disorders, Nijmegen, The Netherlands.
³ Krembil Research Institute, Edmond J. Safra Program in Parkinson's Disease and the Morton and Gloria Shulman Movement Disorders Clinic, Toronto Western Hospital, University Health Network, Toronto, Canada.
⁴ Department of Rehabilitation Sciences, Research Group for Neurorehabilitation (eNRGy), KU Leuven, Leuven, Belgium.

No abstract available

References

1. Fox SH, Katzenschlager R, Lim SY, Barton B, de Bie RMA, Seppi K, Coelho M, Sampaio C (2018) Movement Disorder Society Evidence-Based Medicine Committee. International Parkinson and movement disorder society evidence-based medicine review: Update on treatments for the motor symptoms of Parkinson’s disease. Mov Disord 33, 1248–1266. - PubMed
1. Deutsche Gesellschaft für Neurologie e.V. (DGN) (2023) S-2k-Leitlinie Parkinson-Krankheit. Version 8.1. https://register.awmf.org/de/leitlinien/detail/030-010. Accessed 30 April 2024.
1. Eldemir S, Eldemir K, Saygili F, Ozkul C, Yilmaz R, Akbostancı MC, Guclu-Gunduz A (2024) The effects of standard and modified LSVT BIG therapy protocols on balance and gait in Parkinson’s disease: A randomized controlled trial. Brain Behav 14, e3458. - PMC - PubMed
1. Canning CG, Allen NE, Nackaerts E, Paul SS, Nieuwboer A, Gilat M (2020) Virtual reality in research and rehabilitation of gait and balance in Parkinson disease. Nat Rev Neurol 16, 409–425. - PubMed
1. Ellis TD, Earhart GM (2021) Digital Therapeutics in Parkinson’s Disease: Practical Applications and Future Potential. J Parkinsons Dis 11, 95–101. - PMC - PubMed